Lamb, David J. et al
"BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells." Journal of Pharmacology and Experimental Therapeutics
357.3
(2016):
554-561.
Web. 15 Sept2024.
